GlobeNewswire 4/23/2021 Gilead Sciences submits new drug application in Japan for filgotinib for the treatment of ulcerative...
GlobeNewswire 4/13/2021 OXURION NV to Present at Wet AMD and DME Drug Development Summit
GlobeNewswire 4/8/2021 Extension of lock-up period in Gilead-Galapagos collaboration agreement
GlobeNewswire 4/7/2021 Oxurion NV – Publication in Progress in Retinal Eye Research highlights the potential of pan-RGD int...
GlobeNewswire 4/6/2021 Oxurion NV enters into a Capital Commitment of up to €30 Million with Negma Group
GlobeNewswire 4/5/2021 Chinook Therapeutics Announces Update on Non-Renal Legacy Programs from Aduro Biotech Merger
GlobeNewswire 3/31/2021 OXURION to Participate in Upcoming Investor Meetings
GlobeNewswire 3/25/2021 Publication of the annual report and invitation to the ordinary shareholders’ meeting
GlobeNewswire 3/24/2021 Galapagos appoints Bart Filius as President and Chief Operating Officer
GlobeNewswire 3/19/2021 Galapagos increases share capital through subscription right exercises
GlobeNewswire 3/19/2021 Galapagos Cable Systems and Xtera to deliver advanced submarine network to Ecuador and the Galapagos...
GlobeNewswire 3/17/2021 Oxurion NV Business and Financial Update – FY 2020
GlobeNewswire 3/8/2021 OXURION to Participate in Upcoming Investor Meetings
GlobeNewswire 3/4/2021 GALAPAGOS REPORTS PRIMARY ENDPOINT FOR THE ONGOING FILGOTINIB MANTA AND MANTA-RAy SAFETY STUDIES
GlobeNewswire 3/3/2021 Transparency notification received from The Capital Group
GlobeNewswire 2/18/2021 Pipeline and capital for growth
GlobeNewswire 2/10/2021 Galapagos and Gilead discontinue ISABELA Phase 3 trials in IPF
GlobeNewswire 2/9/2021 The Capital Group holds 10.03% of Galapagos shares
GlobeNewswire 1/21/2021 NICE recommends Jyseleca® ▼(filgotinib) on NHS in landmark decision for rheumatoid arthritis
GlobeNewswire 1/20/2021 Oxurion NV appoints Prof Alan Stitt as Chief Scientific Officer
GlobeNewswire 1/11/2021 Gilead holds 25.54% of Galapagos shares
GlobeNewswire 1/7/2021 OXURION to Participate in Upcoming Investor Meetings
GlobeNewswire 1/6/2021 Galapagos to present at 39th Annual J.P. Morgan Healthcare Conference
GlobeNewswire 1/4/2021 Selvita completes acquisition of Fidelta from Galapagos
GlobeNewswire 12/23/2020 Galapagos’ CEO makes donation of €10 million in the form of personal shares to African Parks